FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:134-136 January 13, 2000 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Takala, J. PubMed Citation

To the Editor: Takala et al. (Sept. 9 issue)¹ report that high-dose growth hormone therapy increased the mortality rate in a group of critically ill patients. Although the causes of death in the patients who died while receiving intensive care were given, the causes of later deaths, which accounted for approximately 20 percent of all deaths, were not. Furthermore, although the mean daily dose of growth hormone was similar in the patients who died and in those who survived, neither the duration of treatment nor the number of patients still receiving treatment at the time of death was given. Thus, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Norhammar, A., Malmberg, K., Ryden, L., Tornvall, P., Stenestrand, U., Wallentin, L., For the Register of Information and Knowledge abou, (2003). Under utilisation of evidence-based treatment partial explanation for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 24: 838-844 [Abstract] [Full Text]  
• Flores-Morales, A., Fernandez, L., Rico-Bautista, E., Umana, A., Negrin, C., Zhang, J.-G., Norstedt, G. (2001). Endoplasmic Reticulum Stress Prolongs GH-Induced Janus Kinase (JAK2)/Signal Transducer and Activator of Transcription (STAT5) Signaling Pathway. Mol. Endocrinol. 15: 1471-1483 [Abstract] [Full Text]